Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P34 - Pathology - Liquid Biopsy
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 10
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P34.02 - Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells From Patients With Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Yuxin Cheng
- Abstract
Loading...
-
+
P72 - Tumor Biology and Systems Biology - Basic and Translational Science - Tumor Microenvironment
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
- Presentations: 10
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P72.01 - Stress-Induced Upregulation of TNFSF4 in Cancer Associated Fibroblasts Facilitates Chemoresistance of Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Yan Li
- Abstract
Loading...
-
+
P75 - Immunotherapy (Phase II/III Trials) - Misc. Topics
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 22
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P75.17 - Baseline D-Dimer Levels Predict Prognosis in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
00:00 - 00:00 | Author(s): Zhibo Zhang
- Abstract
Loading... -
+
P75.18 - Association of the LIPI With Survival and Response in Advanced NSCLC Patients Treated With Immune Checkpoint Inhibitors
00:00 - 00:00 | Author(s): Xiaoyu Zhi
- Abstract
Loading...
-
+
P76 - Targeted Therapy - Clinically Focused - EGFR
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 98
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P76.82 - Osimertinib versus First-Generation EGFR-TKIs in Untreated EGFR-Mutant NSCLC with Brain Metastasis: 362 Real-World Cases
00:00 - 00:00 | Author(s): Yang Zhao
- Abstract
Loading...
-
+
P78 - Immunotherapy (Phase II/III Trials) - Immune Checkpoint Inhibitor Single Agent
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P78.09 - Immunotherapy Beyond Progression for Patients with Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): xiangwei Ge
- Abstract
Loading...
-
+
P79 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Chemotherapy
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 9
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P79.02 - Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLC
00:00 - 00:00 | Presenter: Caicun Zhou
- Abstract
Loading...
-
+
P83 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Targeted Therapy
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P83.01 - Updated Survival and Biomarker Analysis of Camrelizumab and Apatinib in Previously Treated pts of Advanced Non-Squamous NSCLC
00:00 - 00:00 | Presenter: Shengxiang Ren
- Abstract
Loading... -
+
P83.03 - Efficacy of Camrelizumab (SHR-1210) Plus Apatinib in Advanced NSCLC with EGFR Mutation
00:00 - 00:00 | Presenter: Guanghui Gao
- Abstract
Loading...
-
+
P84 - Targeted Therapy - Clinically Focused - ALK
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 23
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P84.17 - Impacts of Different EML4-ALK Variants on the Efficacy of ALK Inhibitors in ALK Positive NSCLC——A Real-World Study in China.
00:00 - 00:00 | Presenter: Zihua Zou
- Abstract
Loading...
-
+
OA07 - Immuno-biology and Novel Immunotherapeutics from Bench to Bed
- Type: Oral
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 11
- Coordinates: 1/30/2021, 10:30 - 11:30, Scientific Program Auditorium
-
+
OA07.06 - Interdependence of KRAS and TP53 Mutations in Predicting ICI Efficacy in EGFR/ALKWT Non-Squamous NSCLC: Results From 1129 Patient-Level Data
10:55 - 11:00 | Author(s): Xiaoyan Li
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma
- Type: Mini Oral
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 13
- Coordinates: 1/30/2021, 16:45 - 17:45, Scientific Program Auditorium
-
+
MA08.11 - Identification of Clinical Features to Predict the Consistency of Mutational Profiles Obtained From Plasma and Tissue of Advanced NSCLC Patient
17:25 - 17:30 | Author(s): Xiao-Dong Jiao
- Abstract
Loading...
